The efficacy and tolerability of adriamycin, bleomycin, vinblastine, dacarbazine and Stanford V in older Hodgkin lymphoma patients: a comprehensive analysis from the North American intergroup trial E2496-Reference-Cited by-同舟云学术

The efficacy and tolerability of adriamycin, bleomycin, vinblastine, dacarbazine and Stanford V in older Hodgkin lymphoma patients: a comprehensive analysis from the North American intergroup trial E2496

Published:2013-01-29 Issue:1 Volume:161 Page:76-86
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Evens Andrew M.¹,Hong Fangxin²,Gordon Leo I.³,Fisher Richard I.⁴,Bartlett Nancy L.⁵,Connors Joseph M.⁶,Gascoyne Randy D.⁶,Wagner Henry⁷,Gospodarowicz Mary⁸,Cheson Bruce D.⁹,Stiff Patrick J.¹⁰,Advani Ranjana¹¹,Miller Thomas P.¹²,Hoppe Richard T.¹¹,Kahl Brad S.¹³,Horning Sandra J.¹⁴

Affiliation:

1. The University of Massachusetts Medical School; Worcester; MA; USA

2. Dana-Farber Cancer Institute and Harvard School of Public Health; Boston; MA; USA

3. Northwestern University Feinberg School of Medicine; Chicago; IL; USA

4. University of Rochester; Rochester; NY; USA

5. Washington University; St. Louis; MO; USA

6. BC Cancer Agency Centre for Lymphoid Cancer; Vancouver; BC; Canada

7. Penn State Cancer Institute; Hershey; PA; USA

8. Princess Margaret Hospital; Toronto; ON; Canada

9. Georgetown University Hospital; Washington; DC; USA

10. Loyola University; Chicago; IL; USA

11. University of Arizona; Tucson; AZ; USA